首页 > 最新文献

ACHD/Valve Disease/Pericardial Disease/Cardiomyopathy最新文献

英文 中文
13 Indexed left atrial volume predicts adverse outcomes independent of the severity of ischaemic mitral regurgitation-a cohort study of 1000 patients following acute myocardial infarction 13指数左心房容积预测与缺血性二尖瓣反流严重程度无关的不良后果——一项1000例急性心肌梗死患者的队列研究
Pub Date : 2020-07-01 DOI: 10.1136/HEARTJNL-2020-BCS.13
H. Sharma, A. Radhakrishnan, S. Brown, J. May, N. Zia, R. Joshi, P. Ludman, J. Townend, S. Doshi, Sohail Q Khan, A. Zaphiriou, S. George, A. Nadir, R. Steeds
Background Ischaemic mitral regurgitation (IMR) is associated with left atrial (LA) dilatation. In patients with primary MR, LA enlargement is an independent predictor of mortality following medical management and mitral valve surgery. The prognostic significance of LA dilatation in IMR post-myocardial infarction (MI) has not been studied. Purpose To determine the impact of LA dilatation on mortality in patients with IMR. Methods 1000 consecutive patients admitted to the Queen Elizabeth Hospital Birmingham with MI who underwent percutaneous coronary intervention were included. Early inpatient TTE was performed within 24-48 hours by accredited echocardiographers using standard multiparametric quantification of IMR, including proximal isovelocity surface area (PISA), effective regurgitant orifice (EROA), vena contracta (VC), and regurgitant volume (RVol). LA size was measured by the recommended biplane method for calculation of LA volume and indexed to body surface area (Mosteller). Analysis was performed on patients with indexed LA volume (LAVi) above and below 34ml/m2 (defined as the upper limit of normal in European Cardiovascular Imaging guidelines). Results MR was observed in 294/1000 patients (29.4%) post-MI, graded as mild (76%), moderate (21%) and severe (3%). A total of 275/294 (94%) had complete chamber volume data. LA dilatation (LAVi > 34ml/m2) was seen in 124 (45%) patients while 151/275 (55%) had normal LA volume (LAVi Although patients with LAVi > 34ml/m2 were older (76+/-11 years vs 70+/-12; p 34ml/m2 accounted for 60% of this mortality. Conclusion IMR patients with LA dilatation have significantly higher mortality than those with normal LA volume. Those with LAVi > 34ml/m2 account for 60% of all IMR mortality, despite fewer ST elevation infarcts and smaller troponin rise. Future studies of intervention for IMR should consider LA dilatation as a potential marker of outcome. Conflict of Interest None
背景:缺血性二尖瓣返流(IMR)与左房(LA)扩张有关。在原发性MR患者中,左室扩大是药物治疗和二尖瓣手术后死亡率的独立预测因子。心肌梗死(MI)后IMR中LA扩张的预后意义尚未研究。目的探讨左室扩张术对IMR患者死亡率的影响。方法对连续1000例在伯明翰伊丽莎白女王医院接受经皮冠状动脉介入治疗的心肌梗死患者进行分析。早期住院患者在24-48小时内由经认证的超声心动图医师使用标准多参数量化IMR,包括近端等速表面积(PISA)、有效反流口(EROA)、收缩静脉(VC)和反流容积(RVol)进行TTE检查。LA尺寸采用推荐的计算LA体积的双翼法测量,并与体表面积指数(Mosteller)。对指数LA容积(LAVi)高于和低于34ml/m2(欧洲心血管成像指南中定义为正常上限)的患者进行分析。结果心肌梗死后,294/1000例(29.4%)患者进行MR检查,分为轻度(76%)、中度(21%)和重度(3%)。共有275/294例(94%)具有完整的腔室容积数据。124例(45%)患者出现LA扩张(LAVi > 34ml/m2),而151/275例(55%)患者的LA容量正常(LAVi)。尽管LAVi > 34ml/m2的患者年龄较大(76+/-11岁vs 70+/-12岁;p34ml /m2占死亡率的60%。结论左室扩张的IMR患者死亡率明显高于左室容量正常的患者。尽管ST段抬高性梗死较少,肌钙蛋白升高较小,但LAVi > 34ml/m2的患者占所有IMR死亡率的60%。未来的IMR干预研究应将左室扩张作为预后的潜在标志。利益冲突无
{"title":"13 Indexed left atrial volume predicts adverse outcomes independent of the severity of ischaemic mitral regurgitation-a cohort study of 1000 patients following acute myocardial infarction","authors":"H. Sharma, A. Radhakrishnan, S. Brown, J. May, N. Zia, R. Joshi, P. Ludman, J. Townend, S. Doshi, Sohail Q Khan, A. Zaphiriou, S. George, A. Nadir, R. Steeds","doi":"10.1136/HEARTJNL-2020-BCS.13","DOIUrl":"https://doi.org/10.1136/HEARTJNL-2020-BCS.13","url":null,"abstract":"Background Ischaemic mitral regurgitation (IMR) is associated with left atrial (LA) dilatation. In patients with primary MR, LA enlargement is an independent predictor of mortality following medical management and mitral valve surgery. The prognostic significance of LA dilatation in IMR post-myocardial infarction (MI) has not been studied. Purpose To determine the impact of LA dilatation on mortality in patients with IMR. Methods 1000 consecutive patients admitted to the Queen Elizabeth Hospital Birmingham with MI who underwent percutaneous coronary intervention were included. Early inpatient TTE was performed within 24-48 hours by accredited echocardiographers using standard multiparametric quantification of IMR, including proximal isovelocity surface area (PISA), effective regurgitant orifice (EROA), vena contracta (VC), and regurgitant volume (RVol). LA size was measured by the recommended biplane method for calculation of LA volume and indexed to body surface area (Mosteller). Analysis was performed on patients with indexed LA volume (LAVi) above and below 34ml/m2 (defined as the upper limit of normal in European Cardiovascular Imaging guidelines). Results MR was observed in 294/1000 patients (29.4%) post-MI, graded as mild (76%), moderate (21%) and severe (3%). A total of 275/294 (94%) had complete chamber volume data. LA dilatation (LAVi > 34ml/m2) was seen in 124 (45%) patients while 151/275 (55%) had normal LA volume (LAVi Although patients with LAVi > 34ml/m2 were older (76+/-11 years vs 70+/-12; p 34ml/m2 accounted for 60% of this mortality. Conclusion IMR patients with LA dilatation have significantly higher mortality than those with normal LA volume. Those with LAVi > 34ml/m2 account for 60% of all IMR mortality, despite fewer ST elevation infarcts and smaller troponin rise. Future studies of intervention for IMR should consider LA dilatation as a potential marker of outcome. Conflict of Interest None","PeriodicalId":152114,"journal":{"name":"ACHD/Valve Disease/Pericardial Disease/Cardiomyopathy","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132982772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
ACHD/Valve Disease/Pericardial Disease/Cardiomyopathy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1